RAB32 and hepatocellular carcinoma: A recent study showed that Rab32 serves as an oncogene in hepatocellular carcinoma with the potential to promote the growth and invasion of tumor cells, while a higher level of Rab32 was strongly related to the advanced tumor stage and poor survival in patients with hepatocellular carcinoma [20].